Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 6Terminated 2Active not recruiting 2Withdrawn 1Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Plasma cell 1Myeloid 1Dermatologic 1

Conditions

Leukemia 11Myelodysplastic Syndromes 7Multiple Myeloma 7Lymphoma, Non-Hodgkin 7Lymphoma 7Leukemia, Myeloid, Acute 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Neoplasms, Plasma Cell 6Myeloproliferative Disorders 6Hodgkin Disease 6Blast Crisis 6Primary Myelofibrosis 5Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myeloid, Accelerated Phase 5Leukemia, Lymphocytic, Chronic, B-Cell 5Congenital Abnormalities 5Burkitt Lymphoma 5Recurrence 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Graft vs Host Disease 4Myelodysplastic-Myeloproliferative Diseases 3Lymphoma, T-Cell, Cutaneous 3Leukemia, Myelomonocytic, Juvenile 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Hairy Cell 3

Interventions

Methotrexate 9Cyclophosphamide 9fludarabine phosphate 7Vincristine 7Rituximab 7Tacrolimus 6Cytarabine 6nelarabine 5Whole-Body Irradiation 5Peripheral Blood Stem Cell Transplantation 5Mycophenolic Acid 5Filgrastim 5Dexamethasone 5Antilymphocyte Serum 5pegaspargase 4merphos 4Prednisone 4Granulocyte Colony-Stimulating Factor 4Etoposide 4Calcium Dobesilate 4tanespimycin 3dexamethasone acetate 3dexamethasone 21-phosphate 3Radiotherapy 3Lenalidomide 3Doxorubicin 3Busulfan 3Bortezomib 3prednylidene 2deltacortene 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Methylprednisolone × Clear all
NCT01005914 2023-01-06

Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

OHSU Knight Cancer Institute

Phase 2 Terminated
11 enrolled 6 charts
LymphoidOther hematologic neoplasm

Leukemia, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00608517 2014-05-20

Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil

Vanderbilt-Ingram Cancer Center

Phase NA Terminated
6 enrolled 13 charts
DermatologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Congenital Abnormalities, Blast Crisis, Burkitt Lymphoma, Graft vs Host Disease, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡